90276-19-0

Basic information

• Product Name: (2E)-3-(2-iodophenyl)prop-2-enoic acid
• Synonyms: (2E)-3-(2-Iodophenyl)acrylic acid; 2-propenoic acid, 3-(2-iodophenyl)-, (2E)-
• CAS NO: 90276-19-0
• Molecular Formula: C₉H₇IO₂
• Molecular Weight: 274.0552
• Mol File: 90276-19-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 360.3°C at 760 mmHg
• Flash Point: 171.7°C
• Density: 1.862g/cm³
• Vapor Pressure: 8.05E-06mmHg at 25°C
• Refractive Index: 1.696
• CAS DataBase Reference: (2E)-3-(2-iodophenyl)prop-2-enoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-3-(2-iodophenyl)prop-2-enoic acid(90276-19-0)
• EPA Substance Registry System: (2E)-3-(2-iodophenyl)prop-2-enoic acid(90276-19-0)

Safety Data

• Hazardous Substances Data: 90276-19-0(Hazardous Substances Data)

Upstream product

• 26260-02-6 2-iodobenzaldehyde 
• 127-09-3 sodium acetate 
• 15310-01-7 benodanil 
• 378759-67-2 ethyl (E)-3-(2-iodophenyl)-2-propenoate 
• 412272-54-9 ethyl 3-(2-iodophenyl)acrylate 
• 609-67-6 2-Iodobenzoyl chloride 
• 5159-41-1 2-iodobenzyl alcohol 
• 121263-09-0 (2-iodo-benzylidene)-malonic acid 
• 7732-18-5 water 
• 141-82-2 malonic acid 
• 39993-62-9 (E)-3-(2-iodophenyl)propenal 
• 1664-63-7 2-amino-cinnamic acid 
• 615-43-0 2-iodophenylamine 

Downstream Products

• 55170-65-5 2-Oxo-1(2H)-chinolinessigsaeure 
• 122951-06-8 ethyl 3-(2-iodophenyl)propanoate 
• 1417698-31-7 (2E)-3-(3-hydroxy-4-methoxyphenyl)-N-(2-{[(2E)-3-(2-iodophenyl)prop-2-enoyl]amino}ethyl)-2-(3,4,5-trimethoxyphenyl)acrylamide 
• 1417698-30-6 tert-butyl (2-{[(2E)-3-(2-iodophenyl)prop-2-enoyl]amino}ethyl)carbamate 
• 1417698-28-2 (2E)-N-(2-aminophenyl)-3-(2-iodophenyl)acrylamide 
• 1027219-61-9 (E)-3-(2-Iodo-phenyl)-acryloyl azide 
• 1026955-47-4 3-bromo-3-(2-iodo-phenyl)-propionyl chloride 
• 817623-35-1 4-bromo-4-(2-iodophenyl)-1-diazo-2-butanone 
• 1025951-73-8 3-bromo-3-(2-iodo-phenyl)-propionic acid 
• 639785-12-9 2-iodo-cinnamoyl chloride 
• 96606-95-0 3-(2-iodophenyl)propanoic acid 
• 378759-67-2 ethyl (E)-3-(2-iodophenyl)-2-propenoate 

Relevant articles and documents

SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER

The present invention relates to a pharmaceutical composition for treating and/or alleviating a psychiatric disorder comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a pharmaceutical composition for inducing anti-stress, anti-anxiety and/or anti-depressant activities comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient.

Selective Palladium-Catalyzed Domino Heck/Buchwald–Hartwig Arylations of N-Glycosylcinnamamides: An Efficient Route to 4-Aryl-N-glycosylquinolin-2-ones

An efficient and selective domino Heck/Buchwald–Hartwig arylations of readily available N-glycosylcinnamamides with aryl iodides have been established. Using palladium(II) acetate as a catalyst, potassium acetate as the base and tetrabutylamonium bromide as an additive in dioxane, the protocol proved to be general, and a variety of 4-aryl-N-glycosylquinolin-2-ones has been prepared in good yields with exclusive α- or β-selectivity. (Figure presented.).

PHENYLALKYL SULFAMATE COMPOUND AND MUSCLE RELAXANT COMPOSITION COMPRISING THE SAME

The present invention relates to novel phenylalkyl sulfamate compounds, a method for preventing or treating a disease associated with muscle spasm. The present invention ensures the enhancement of muscle relaxation activity essential for alleviation of muscle spasm, such that it is promising for preventing or treating various diseases associated with muscle spasm.